Search
for
Sort by
Research 61–90 of 1000+
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- Topical Janus kinase inhibitors: A review of applications in dermatology
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Association of Janus kinase inhibitors with reduced depression in alopecia areata
- Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- BH14 Irish dermatologists’ experience with Janus kinase inhibitors in alopecia areata
- 151 Efficacy and adverse effects of oral Janus kinase inhibitor (JAKi) use in patients with lichen planopilaris: a retrospective case series and systematic review
- Supplementary Material for: Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- BH21 Efficacy and safety of oral Janus kinase inhibitors in the treatment of alopecia areata: a systematic review and meta-analysis
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- Comparative Efficacy Evaluation of Alopecia Areata Management with Janus Kinase Inhibitors in Children: Retrospective Cohort Study
- Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- P123 : Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and metaanalysis
- Oral Baricitinib Restores Hair Loss in Alopecia Areata
- Baricitinib: A Review in Severe Alopecia Areata
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Inhibiting Janus kinases to treat alopecia areata
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Baricitinib for the Treatment of Alopecia Areata
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- The role of janus kinases in the treatment of autoimmune skin diseases
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis